Leili Behrooz1, Diana S Balekian2, Mohammad Kamal Faridi3, Janice A Espinola3, Liam P Townley3, Carlos A Camargo4. 1. Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: lbehrooz@mah.harvard.edu. 2. Asthma and Allergy Affiliates, Salem, MA, USA. 3. Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA. 4. Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Maternal prenatal smoking has adverse effects on the growing fetus including those of respiratory nature. Although postnatal smoke exposure is a risk factor for respiratory infections, the effects of prenatal smoking independent of postnatal smoke exposure are less established. We hypothesized that both maternal prenatal smoking, and postnatal smoke exposure are risk factors for severe bronchiolitis during infancy. METHODS: We performed a case-control study of 1353 children born between 1996 and 2011 at a single teaching hospital. Cases were admitted to the same hospital for bronchiolitis during infancy. Maternal prenatal smoking was collected from birth records. Postnatal smoke exposure was collected from review of electronic health records. Multivariable logistic regression was used to evaluate the independent associations of the two smoking variables with severe bronchiolitis. RESULTS: 6% of cases were exposed to maternal prenatal smoking, compared with 4% of controls (P = 0.10). Postnatal smoke exposure was present in the households of 17% of cases compared with 3% of controls (P < 0.001). In a multivariable model with both smoking variables and adjustment for 10 covariates, maternal prenatal smoking was not a significant risk factor for severe bronchiolitis (adjusted OR = 1.02, 95%CI 0.56-1.84). By contrast, postnatal smoke exposure was associated with >300% increased odds (adjusted OR 4.19, 95%CI 2.51-6.98). CONCLUSIONS: Although maternal prenatal smoking has many known adverse effects, it was not associated with increased odds of severe bronchiolitis in either unadjusted or multivariable analyses. Postnatal smoke exposure was a consistently strong risk factor. Our findings support ongoing efforts to decrease infant exposure to ambient smoke.
BACKGROUND: Maternal prenatal smoking has adverse effects on the growing fetus including those of respiratory nature. Although postnatal smoke exposure is a risk factor for respiratory infections, the effects of prenatal smoking independent of postnatal smoke exposure are less established. We hypothesized that both maternal prenatal smoking, and postnatal smoke exposure are risk factors for severe bronchiolitis during infancy. METHODS: We performed a case-control study of 1353 children born between 1996 and 2011 at a single teaching hospital. Cases were admitted to the same hospital for bronchiolitis during infancy. Maternal prenatal smoking was collected from birth records. Postnatal smoke exposure was collected from review of electronic health records. Multivariable logistic regression was used to evaluate the independent associations of the two smoking variables with severe bronchiolitis. RESULTS: 6% of cases were exposed to maternal prenatal smoking, compared with 4% of controls (P = 0.10). Postnatal smoke exposure was present in the households of 17% of cases compared with 3% of controls (P < 0.001). In a multivariable model with both smoking variables and adjustment for 10 covariates, maternal prenatal smoking was not a significant risk factor for severe bronchiolitis (adjusted OR = 1.02, 95%CI 0.56-1.84). By contrast, postnatal smoke exposure was associated with >300% increased odds (adjusted OR 4.19, 95%CI 2.51-6.98). CONCLUSIONS: Although maternal prenatal smoking has many known adverse effects, it was not associated with increased odds of severe bronchiolitis in either unadjusted or multivariable analyses. Postnatal smoke exposure was a consistently strong risk factor. Our findings support ongoing efforts to decrease infant exposure to ambient smoke.
Authors: Hannah Burke; Jo Leonardi-Bee; Ahmed Hashim; Hembadoon Pine-Abata; Yilu Chen; Derek G Cook; John R Britton; Tricia M McKeever Journal: Pediatrics Date: 2012-03-19 Impact factor: 7.124
Authors: J Cano Fernández; C Zabaleta Camino; E de la Torre Montes de Neira; G A Yep Chullen; J M Melendi Crespo; M Sánchez Bayle Journal: An Pediatr (Barc) Date: 2003-02 Impact factor: 1.500
Authors: Joseph P Bradley; Leonard B Bacharier; JoAnn Bonfiglio; Kenneth B Schechtman; Robert Strunk; Gregory Storch; Mario Castro Journal: Pediatrics Date: 2005-01 Impact factor: 7.124
Authors: V Fuentes-Leonarte; M Estarlich; F Ballester; M Murcia; A Esplugues; J J Aurrekoetxea; M Basterrechea; A Fernández-Somoano; E Morales; M Gascón; A Tardón; M Rebagliato Journal: Indoor Air Date: 2014-06-21 Impact factor: 5.770
Authors: Joseph R DiFranza; Anthony Masaquel; Amy M Barrett; Ann D Colosia; Parthiv J Mahadevia Journal: BMC Pediatr Date: 2012-06-21 Impact factor: 2.125
Authors: Nipuni Nilakshini Wimalasena; Alice Chang-Richards; Kevin I-Kai Wang; Kim N Dirks Journal: Int J Environ Res Public Health Date: 2021-03-10 Impact factor: 3.390